In the rapidly evolving world of pharmaceutical regulations, AI is becoming a game-changer. Read the latest article from Outsourcing-Pharma where our CEO and Founder, Caroline Shleifer shares her insights about the latest advancements and upcoming trends in regulatory intelligence. Read the complete article here: https://lnkd.in/dFZgYzS5 #Innovation #Pharma #RegulatoryTech #Regtech #RegASK #Compliance #PharmaRegulations
RegASK
Technology, Information and Internet
Singapore, Singapore 17,859 followers
Expert Guidance. Cost Efficient. Fast Turnaround. We are hiring! Visit our Careers page on regask.com
About us
Using artificial intelligence for augmenting regulatory research and ESG issues management. RegASK™’s digital platform routinely monitors, anticipates and reports updates or changes to relevant regulations with instant alerts. Our platform also allows us to zero-in on applicable regulations to identify and analyze any gaps in the compliance of a product. RegASK™ was created by the founders of SPRIM, after more than 17 years of consulting on globalization projects and researching regulatory guidelines for healthcare companies across six of the seven continents. RegASK™ is backed by a team of regulatory experts with a global perspective and years of navigating some of the most complicated regulatory hurdles in markets big and small.
- Website
-
https://www.regask.com/
External link for RegASK
- Industry
- Technology, Information and Internet
- Company size
- 11-50 employees
- Headquarters
- Singapore, Singapore
- Type
- Privately Held
- Founded
- 2017
- Specialties
- regulatory consulting, regulatory research, path to market, regulatory dossier preparation, regulatory affairs consulting, path to claims, importation, product labeling, SaaS platform, RegTech, cosmetics regulatory compliance, food and drug compliance, regulatory intelligence, regulatory software solutions, regulatory strategy, FMCG, food or dietary supplements compliance, decentralized clinical trials compliance, Risk Management , and Supply Chain Management
Locations
-
Primary
79 Science Park Drive
Singapore, Singapore 118264, SG
-
3452 Lake Lynda Drive, Bldg 100
Orlando, Florida 32817, US
-
Avenue de Tourbillon 100
Sion, Valais 1950, CH
Employees at RegASK
-
Isabelle Caelen
Global Head of Regulatory Affairs at RegASK™
-
Alice Gravereaux Baertschiger
Senior Regulatory Affairs project manager
-
Linda Lattuca
Freelance Food Labelling Compliance Expert (24 Languages), in accordance with EU/non EU Regs. Translator. Journalist.
-
Fabienne JAUTARD
Sales expert with 20+ years of experience in business development and customer management. Sustainability advocate
Updates
-
Explore the transformative role of AI in regulatory intelligence through the lens of our Founder and CEO, Caroline Shleifer’s pioneering work. Discover more in BioPharma-Reporter's latest feature, where she offers an in-depth look at the advancements in compliance strategies within the biopharma sector. Read the complete article here: https://lnkd.in/dpyVCzbt #Biopharma #AI #RegulatoryIntelligence #Innovation #Compliance #Regtech #RegASK
Caroline Shleifer on founding RegASK and her journey in science and regulatory affairs
biopharma-reporter.com
-
🚀 Explore the transformative impact of AI on compliance within the pharmaceutical and medtech industries! Gain valuable insights into the latest advancements and regulatory efforts in this must-read article featured on Corporate Compliance Insights by our CEO and Founder, Caroline Shleifer . Read the full article here: https://hubs.ly/Q02GMP-10 Thank you Corporate Compliance Insights for the mention. #RegASK #RegGenius #MedTech #Pharma #Compliance #Regulations
Practitioners in the pharmaceutical and medical technology sector are no strangers to regulation, and to be sure, rules governing #ArtificialIntelligence in medicine are coming. RegASK's Caroline Shleifer examines efforts by states and the FDA to put up guardrails around the technology. https://hubs.ly/Q02GMP-10 #Compliance
AI’s Impact on Pharma and MedTech Compliance
https://www.corporatecomplianceinsights.com
-
We are excited to see our Chief Product Technology Officer, Amenallah Reghimi featured in Clinical Trials Arena discussing the role of AI in navigating regulatory compliance. Discover how our AI chatbot is helping understand the complexities of AI regulation in drug and device development. Read the full interview here: https://lnkd.in/d8Kuv-B4 Clinical Trials Arena thank you for the spotlight. #RegASK #AI #InnovationInAI #REGGenius
Interview - How can (A)I help? AI chatbot to help understand the world of AI regulation As more regulatory bodies release guidance about the use of AI in drug and device development, the chances of not fully adhering increases. The Clinical Trials Arena team spoke with RegASK’s chief product technology officer (CPTO) Amenallah Reghimi about the new guidance’s and how this software provides the answers sponsors need, especially considering the ability for interpretation. - https://lnkd.in/dZQAtNpD #clinicaltrials #ai #aiinhealthcare #aichatbot #chatbot #airegulation #drugdevelopment
How can (A)I help? AI chatbot to help understand the world of AI regulation
clinicaltrialsarena.com
-
🚨 TGA Updates Permitted Ingredient List for Listed Medicines, Including Complementary Medicines and OTC Products, June 2024 🚨 On June 06, 2024, the Therapeutic Goods Administration (TGA) released an update to the list of ingredients permitted in listed medicines. This update, part of a routine revision process, ensures that the list of approved substances remains current and safe. 🔹 New Ingredients Added: With specific conditions to ensure safe use. 🔹 Re-evaluation of Existing Ingredients: Some ingredients have revised conditions or have been removed based on new evidence. 🔹 Stricter Labeling Requirements: Enhancing consumer and healthcare professional safety. 🔹 Updated Permissible Levels: Reflecting the latest safety data. 🔹 Transition Period: Starting from June 14, 2024, for manufacturers to comply with new requirements. 📄 For more details, read the full update on https://hubs.la/Q02Dc2z50 #Pharmaceuticals #HealthCare #TGA #ListedMedicines #RegulatoryAffairs #ComplementaryMedicine #SafetyUpdates #HealthcareIndustry#Regulatory Intelligence
-
-
Hear what our customer, Farouk Systems have to say about us - Real Voices, Real Results. Learn how RegASK helped Anthony and his team at Farouk Systems keep themselves proactively updated about proposition 65 changes and act on them in a timely and efficient manner. Thank you, Farouk Systems for choosing us as your compliance partner and for your valuable recommendation. #RegAsk #CustomerStories #Testimonial #SuccessStories
-
🚨 EU Takes Decisive Action Against False Green Labeling! 🚨 The EU is stepping up its game to clean up misleading environmental claims. 🌿 The Council has just adopted its position on the Green Claims Directive, and it's set to revolutionize how companies market their eco-friendliness. 🚫💚 Why is this a big deal? No More Greenwashing: Companies must now back up their environmental claims with clear criteria and scientific evidence. Vague and misleading claims are out! 📉❌ Verified Truth: All green claims will need third-party verification before they can be published. No more taking claims at face value. 🔍✔️ SME Support: Small businesses will get extra time and resources to comply, ensuring they can keep up without being overwhelmed. 🏢🛠️ This directive is a powerful move to ensure that when products claim to be green, they truly are. 🌍 The EU is cracking down on false labeling to help consumers make informed, trustworthy choices. 🌱 Negotiations with the European Parliament are up next. Stay up to date with RegAsk as we move closer to a cleaner, more transparent market! 🌟 https://hubs.la/Q02CqG_70 #EU #GreenClaims #AntiGreenwashing #EcoFriendly #Sustainability #ClimateAction #GreenDeal Let's make green mean green! 💚🌿🚀
EU Green Claims Directive: Council Moves Forward with Negotiations | RegASK
https://regask.com
-
We are thrilled to announce Andrew Dalton’s appointment as our new Chief Revenue Officer! 🎉 With over 15 years of business development and sales leadership experience in life sciences and technology, Andrew is set to drive RegASK’s global growth and elevate our AI-driven regulatory intelligence to new heights. Andrew's impressive background spans MedTech, BioTech, and BioPharma across the U.S. and EMEA markets. His expertise will be invaluable in helping regulatory affairs teams worldwide manage compliance risks and enhance workflow efficiencies throughout the product lifecycle. Join us in welcoming Andrew to the RegASK family! 🌍✨ For more information, visit https://hubs.la/Q02CbngL0. #Leadership #RegulatoryIntelligence #AI #LifeSciences #Growth #Compliance #RegASK
-
-
🚀 • RegASK joins NVIDIA Inception Program!! We’re proud to share that RegASK has been selected to join the NVIDIA Inception Program. This collaboration will supercharge the development of RegGenius (https://hubs.la/Q02C9yb-0), our AI-driven copilot that helps organizations manage the constantly changing regulatory landscape. Being part of the NVIDIA Inception Program means access to NVIDIA’s exceptional resources and expertise, accelerating our efforts to deliver cutting-edge, AI-powered solutions for seamless regulatory compliance. A big thanks to NVIDIA for this incredible opportunity. We’re excited about the journey ahead and the innovations RegASK bring to regulatory intelligence and compliance management. Stay tuned for updates! #RegASK #NVIDIAInception #RegGenius #AI #Compliance #RegulatoryIntelligence #Innovation #TechNews
-
-
🍽️ RegAlert! New Scientific Nutrition Advice from ANSES French Food Agency to Avoid Weight Gain 🍽️ On May 29, 2024, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) released crucial nutrition advice focusing on the temporal distribution of food intake. Read more on https://hubs.la/Q02zYfnc0 #Nutrition #Health #ANSES #WeightManagement #HealthyEating #ScientificAdvice
French Food Agency Releases Scientific Nutrition Advice To Avoid Gain Weight | RegASK
https://regask.com